The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series

Ofatumumab (OFA) is an anti-CD20 antibody. We assessed the therapeutic potential of OFA in five pediatric anti-NMDAR encephalitis patients who showed poor responses to the first-line immunotherapy. OFA treatment showed clinical improvement including alleviation of clinical symptoms and mRS decrease...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenlin Wu, Jie Hong, Yanping Ran, Wenxiao Wu, Haixia Zhu, Chi Hou, Yuanyuan Gao, Yulin Tang, Yinting Liao, Wen-Xiong Chen, Xiaojing Li
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024167114
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850245205819654144
author Wenlin Wu
Jie Hong
Yanping Ran
Wenxiao Wu
Haixia Zhu
Chi Hou
Yuanyuan Gao
Yulin Tang
Yinting Liao
Wen-Xiong Chen
Xiaojing Li
author_facet Wenlin Wu
Jie Hong
Yanping Ran
Wenxiao Wu
Haixia Zhu
Chi Hou
Yuanyuan Gao
Yulin Tang
Yinting Liao
Wen-Xiong Chen
Xiaojing Li
author_sort Wenlin Wu
collection DOAJ
description Ofatumumab (OFA) is an anti-CD20 antibody. We assessed the therapeutic potential of OFA in five pediatric anti-NMDAR encephalitis patients who showed poor responses to the first-line immunotherapy. OFA treatment showed clinical improvement including alleviation of clinical symptoms and mRS decrease accompanied by anti-NMDAR antibody turning negative in 3 patients and decline in 2 patients. And all patients achieved B cell depletion after OFA treatment. During follow-up, all patients’ symptoms were stable. OFA treatment is safe and effective, easy to administer, and favorable for pediatric anti-NMDAE encephalitis patients who are refractory to the first-line immunotherapy.
format Article
id doaj-art-f95d2e96d1cc4894aaa2b32ddc59fdd9
institution OA Journals
issn 2405-8440
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-f95d2e96d1cc4894aaa2b32ddc59fdd92025-08-20T01:59:31ZengElsevierHeliyon2405-84402024-12-011023e4068010.1016/j.heliyon.2024.e40680The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case seriesWenlin Wu0Jie Hong1Yanping Ran2Wenxiao Wu3Haixia Zhu4Chi Hou5Yuanyuan Gao6Yulin Tang7Yinting Liao8Wen-Xiong Chen9Xiaojing Li10Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaDepartment of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaCorresponding author. Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City No.9, Jinsui Road, Tianhe District, Guangzhou City, 510623, Guangdong Province, China.; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaCorresponding author. Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, No.9, Jinsui Road, Tianhe District, Guangzhou City, 510623, Guangdong Province, China.; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, ChinaOfatumumab (OFA) is an anti-CD20 antibody. We assessed the therapeutic potential of OFA in five pediatric anti-NMDAR encephalitis patients who showed poor responses to the first-line immunotherapy. OFA treatment showed clinical improvement including alleviation of clinical symptoms and mRS decrease accompanied by anti-NMDAR antibody turning negative in 3 patients and decline in 2 patients. And all patients achieved B cell depletion after OFA treatment. During follow-up, all patients’ symptoms were stable. OFA treatment is safe and effective, easy to administer, and favorable for pediatric anti-NMDAE encephalitis patients who are refractory to the first-line immunotherapy.http://www.sciencedirect.com/science/article/pii/S2405844024167114RefractoryAnti-NMDAR encephalitisChildrenOfatumumab
spellingShingle Wenlin Wu
Jie Hong
Yanping Ran
Wenxiao Wu
Haixia Zhu
Chi Hou
Yuanyuan Gao
Yulin Tang
Yinting Liao
Wen-Xiong Chen
Xiaojing Li
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
Heliyon
Refractory
Anti-NMDAR encephalitis
Children
Ofatumumab
title The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
title_full The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
title_fullStr The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
title_full_unstemmed The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
title_short The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
title_sort therapeutic effect of ofatumumab in pediatric anti nmdar encephalitis a case series
topic Refractory
Anti-NMDAR encephalitis
Children
Ofatumumab
url http://www.sciencedirect.com/science/article/pii/S2405844024167114
work_keys_str_mv AT wenlinwu thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT jiehong thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yanpingran thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT wenxiaowu thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT haixiazhu thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT chihou thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yuanyuangao thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yulintang thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yintingliao thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT wenxiongchen thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT xiaojingli thetherapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT wenlinwu therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT jiehong therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yanpingran therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT wenxiaowu therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT haixiazhu therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT chihou therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yuanyuangao therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yulintang therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT yintingliao therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT wenxiongchen therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries
AT xiaojingli therapeuticeffectofofatumumabinpediatricantinmdarencephalitisacaseseries